| Dr Zhi Qiao, MD | |
|
2100 Dorchester Ave, Dorchester Center, MA 02124-5615 | |
| (617) 506-4360 | |
| (617) 506-4366 |
| Full Name | Dr Zhi Qiao |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 2100 Dorchester Ave, Dorchester Center, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700988078 | NPI | - | NPPES |
| 03080233 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 251684 (New York) | Primary |
| 208M00000X | Hospitalist | 242368 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carney Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Entity Name | Sound Physicians Of Massachusetts Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740678408 PECOS PAC ID: 2062554637 Enrollment ID: O20100120000133 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Entity Name | Steward St. Annes Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932411493 PECOS PAC ID: 3678760493 Enrollment ID: O20101206001124 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Entity Name | New England Sinai Hospital A Steward Family Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851646087 PECOS PAC ID: 5193972123 Enrollment ID: O20130118000243 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Entity Name | Sound Physicians Of Massachusetts Ii Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306376397 PECOS PAC ID: 9436421567 Enrollment ID: O20170823003703 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zhi Qiao, MD 2100 Dorchester Ave, Dorchester Center, MA 02124-5615 Ph: (617) 506-4360 | Dr Zhi Qiao, MD 2100 Dorchester Ave, Dorchester Center, MA 02124-5615 Ph: (617) 506-4360 |
News Archive
The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.
Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
› Verified 7 days ago
Dr. Gerard Lawrence Gaughan, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2100 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-4000 | |
Dr. Paul Elliott Boinay Jr., MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2100 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-4000 Fax: 617-474-3860 | |
Evgenia Forman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2216 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-5100 | |
Dr. Roger Schutt, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2100 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-4000 Fax: 617-474-3856 | |
Alvina Sahar, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2100 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-4000 | |
Dr. Sheldon S Lockman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2100 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-4000 Fax: 617-296-7494 | |
Laide Bello, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2100 Dorchester Ave, Carney Hospital, 7th Floor, Dorchester Center, MA 02124 Phone: 617-883-6086 |